Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maralixibat in Intrahepatic Cholestasis of Pregnancy
NCT07389031Phase 2Not yet recruiting
- Sponsor
- Imperial College London
- Start
- Apr 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of maralixibat in intrahepatic cholestasis of pregnancy (ICP), sponsored by Imperial College London. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
maralixibat
03
Conditions
intrahepatic cholestasis of pregnancy (ICP)
Beyond the preview
Go deeper on NCT07389031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07389031.